The Trump administration's proposal to freeze Medicare Advantage payment rates and recalibrate risk adjustment methodology generated record public comment volume to CMS, signaling extraordinary industry mobilization from insurers, providers, and patient advocates. This is not routine regulatory process—the comment surge reflects existential stakes for the MA market, which now covers nearly 29 million beneficiaries (42% of Medicare) and generates $400+ billion in annual spending.

Flat MA rates combined with risk-adjustment changes would compress insurer profit margins, especially for regional carriers, and force network contraction in rural and underserved markets. CMS Administrator Dr. Mehmet Oz and CMMI Director Abe Sutton have signaled aggressive intent to push providers into mandatory value-based models and constrain MA insurer behavior. The administration views MA as bloated and competitive pressure on provider networks will intensify. Primary care practices and specialists in MA-heavy regions (Florida, Arizona, Texas, California) should expect contract renegotiations and potential network exclusions if their quality/cost metrics lag peers.

For dental, MA dental benefits remain thin and low-reimbursement. However, integrated dental-medical practices and DSOs serving MA populations will face network pressure and reduced patient volume if insurers trim benefits or narrow networks to offset payment freezes. Hospital executives should anticipate MA insurers shifting risk back to provider groups and demanding higher performance guarantees on readmission and quality metrics.

Final CMS rule expected by November 2026; implementation January 2027. Monitor Q2 public comment summaries for insurer pushback and proposed amendments.